- Home
- WNEB vs BWAY Comparison
WNEB vs BWAY Comparison
Compare WNEB & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- BWAY
- Stock Information
- Founded
- WNEB 1853
- BWAY 2003
- Country
- WNEB United States
- BWAY Israel
- Employees
- WNEB N/A
- BWAY N/A
- Industry
- WNEB Savings Institutions
- BWAY Medical/Dental Instruments
- Sector
- WNEB Finance
- BWAY Health Care
- Exchange
- WNEB Nasdaq
- BWAY Nasdaq
- Market Cap
- WNEB 191.1M
- BWAY 177.4M
- IPO Year
- WNEB N/A
- BWAY 2019
- Fundamental
- Price
- WNEB $8.92
- BWAY $10.69
- Analyst Decision
- WNEB Hold
- BWAY Strong Buy
- Analyst Count
- WNEB 3
- BWAY 3
- Target Price
- WNEB $8.50
- BWAY $13.17
- AVG Volume (30 Days)
- WNEB 40.7K
- BWAY 51.4K
- Earning Date
- WNEB 02-04-2025
- BWAY 03-05-2025
- Dividend Yield
- WNEB 3.14%
- BWAY N/A
- EPS Growth
- WNEB N/A
- BWAY N/A
- EPS
- WNEB 0.52
- BWAY 0.04
- Revenue
- WNEB $72,500,000.00
- BWAY $38,631,000.00
- Revenue This Year
- WNEB N/A
- BWAY $388.82
- Revenue Next Year
- WNEB $6.24
- BWAY $18.70
- P/E Ratio
- WNEB $17.26
- BWAY $137.57
- Revenue Growth
- WNEB N/A
- BWAY 34.19
- 52 Week Low
- WNEB $6.00
- BWAY $4.61
- 52 Week High
- WNEB $10.08
- BWAY $11.25
- Technical
- Relative Strength Index (RSI)
- WNEB 45.35
- BWAY 62.56
- Support Level
- WNEB $8.51
- BWAY $10.08
- Resistance Level
- WNEB $9.20
- BWAY $11.25
- Average True Range (ATR)
- WNEB 0.17
- BWAY 0.37
- MACD
- WNEB 0.01
- BWAY 0.15
- Stochastic Oscillator
- WNEB 57.75
- BWAY 72.96
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.